(Q51564741)
Statements
Development of cardiovascular drugs: the U.S. regulatory milieu from the perspective of a participating nonregulator. (English)
1 reference
Jeffrey S Borer
1 reference
1 December 2004
1 reference
44
1 reference
12
1 reference
2285-2292
1 reference